BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Biotech Bay

  CollabRx Launches Targeted Therapy Finder

  January 18, 2011

   · 

  8 min read
• InnovaStem GmbH Release: Manufacturing License for Separation of Stem Cells from Cord Blood

  January 18, 2011

   · 

  3 min read
• BioCapital

  Immune Response BioPharma Announces Plans to Develop NeuroVax a Novel Therapeutic Vaccine for Multiple Sclerosis

  January 18, 2011

   · 

  2 min read
• Lone Star Bio

  Texas Heart Institute at St. Luke’s Episcopal Hospital Cardiologists First in Houston to Use Breakthrough Imaging to Better Diagnose and Treat Patients with Blocked Arteries

  January 18, 2011

   · 

  1 min read
• Pharm Country

  Johnson & Johnson’s McNeil Consumer Healthcare Faults Cleaning Procedures In Massive Recalls; Announces New Recall of 50 Million More Bottles of Medicines

  January 18, 2011

   · 

  2 min read
• Policy

  Transcept Pharmaceuticals, Inc. Resubmits Intermezzo(R) New Drug Application for the Treatment of Middle of the Night Awakenings

  January 18, 2011

   · 

  3 min read
• Pharm Country

  Anavex Life Sciences Corp. Comments on President Obama’s Signing of National Alzheimer’s Project Act into Law

  January 18, 2011

   · 

  4 min read
• Biotech Beach

  New Phenomenex, Inc. Sorbent is Designed and Tested for Drugs of Abuse Extraction in Forensic Toxicology

  January 18, 2011

   · 

  1 min read
• Business

  Johns Hopkins Brain Science Institute Forges Agreement to Develop Novel Therapeutics for Neurological and Psychiatric Disorders

  January 18, 2011

   · 

  1 min read
• Drug Development

  CureFAKtor Pharmaceuticals. LLC Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer

  January 18, 2011

   · 

  5 min read